Memorandum

Mid-sized chemical companies speak for TTIP

The intensive trade relations with the USA contribute to mid-sized chemical companies creating and securing employment with above-average pay in Germany. Therefore, eliminating tariffs, cooperation in future framework conditions and effective rules for investor protection are important concerns also and especially for mid-sized businesses within the industry. In a joint memorandum, mid-sized chemical companies clearly underline their support for TTIP.

Mid-sized entrepreneurs from the chemical industry underline with their signature: The thime is ripe for TTIP! - Photo: © Adam Tomasik - Fotolia
Mid-sized entrepreneurs from the chemical industry underline with their signature: The thime is ripe for TTIP! - Photo: © Adam Tomasik - Fotolia

We – mid-sized entrepreneurs from the chemical industry – support with full conviction the Transatlantic Trade and Investment Partnership (TTIP). The time is ripe for TTIP!

The USA is the most important foreign market outside the EU for the German chemical industry. In 2014 the industry exported goods worth around 15 billion euros to the United States. Our surplus in transatlantic trading is over 4 billion euros. The intensive trade relations with the USA contribute to mid-sized chemical companies creating and securing employment with above-average pay in Germany.

We need open markets to continue this success story. Irrespective of the controversial discussions about TTIP among politicians and in society, the worldwide largest free trade zone of the future will be an important component for this. Eliminating tariffs, cooperation in future framework conditions and effective rules for investor protection – especially for mid-sized businesses – are important concerns of the industry.

  • Tariffs: German companies pay ca. 140 million euros annually in tariffs for their exports of chemical and pharma products to the USA; US suppliers pay some 230 million euros in tariffs for their exports to Germany. This unnecessarily increases the costs for our inputs that we obtain from the United States.
  • Regulatory cooperation: The chance of regulatory cooperation opens up immense possibilities. Duplication and bureaucracy can be avoided for existing regulation. For example, standards for labelling or quality assurance in the chemical industry – to the extent that they are comparable – can be mutually recognized without any problems. For future regulation, transparent consultations can lead to a long-term regulatory convergence – while maintaining regulatory autonomy on both sides of the Atlantic.
  • Investor protection: Investor protection is particularly important for mid-sized companies. Especially small and medium-sized undertakings cannot afford costly legal assistance, as is needed e.g. when filing legal claims stateside. For this reason, straightforward and transparent investor protection rules are a gain particularly for mid-sized companies. Removing this block of issues from the negotiations would be equal to an “ostrich policy”, and this would be the wrong way. But we, too, see a need for reform for the instrument of investor-to-state dispute settlement. One approach could be to set up an international tribunal as a permanent instance of revision.

Therefore, we are calling upon politicians to advocate a successful conclusion of TTIP. TTIP opens up the historic chance of creating a strong transatlantic economic area. With more growth and prosperity for Germany and Europe.

Mid-sized chemical companies say Yes to TTIP.
Let us use this historic chance!

The following companies support this call:

AbbVie Deutschland GmbH & Co.KG
ADVANSA GmbH
Allessa GmbH
Börlind Gesellschaft für kosmetische Erzeugnisse mbH
BÜFA GmbH & Co. KG
Cordenka GmbH & Co. KG
Crespel & Deiters GmbH & Co. KG
CSC JÄKLECHEMIE GmbH & Co. KG
Cyberbond Europe GmbH
DELO Industrie Klebstoffe GmbH & Co. KGaA
Deutsche Homöopathie-Union DHU-Arzneimittel GmbH & Co. KG
Dr. Paul Lohmann GmbH KG
Dr. Rimpler GmbH
Dyckerhoff GmbH
DYMAX Europe GmbH
Emil Frei GmbH & Co. KG
EMS-CHEMIE (Neumünster) GmbH & Co. KG
Ernst Diegel GmbH
Follmann Chemie GmbH
GELITA AG
Greiner Bio-One GmbH
GXC Coatings GmbH
HOBUM Oleochemicals GmbH
IBU-tec advanced materials AG
Kelheim Fibres GmbH
KEMPER SYSTEM GmbH & Co. KG
Kiesel Bauchemie GmbH u. Co. KG
KLEBCHEMIE M. G. Becker GmbH & Co. KG
KÖSTER BAUCHEMIE AG
Krahn Chemie GmbH
LANKWITZER LACKFABRIK GmbH
Lehmann & Voss & Co. KG
LUGATO GmbH & Co KG
MOTIP DUPLI GmbH
Nabaltec AG
W. Neudorff GmbH KG
ORGANICA Feinchemie GmbH
Panacol-Elosol GmbH
Paul Bauder GmbH & Co. KG
Peter Greven Physioderm GmbH
Peter-Lacke GmbH
PETROFER CHEMIE H. R. Fischer GmbH & Co KG
PHARMORGANA GmbH
Poliboy-Werk Emigholz & Brandt GmbH
Reimbold&Strick Handels- u. Entwicklungsges. f. chemisch-keramische Produkte mbH
REPHA GmbH Biologische Arzneimittel
SANUM-KEHLBECK GmbH & Co. KG
SCHÖNOX GMBH
Sherwin-Williams Deutschland GmbH
Sika Deutschland GmbH
Steuler-Gruppe
Trevira GmbH
wedi GmbH
WeylChem Frankfurt GmbH
Worlée-Chemie GmbH

For questions or suggestions, please feel free to contact us.

Contacts

Martin Stuhl

E-Mail: stuhl@vci.de

Norbert Theihs

E-Mail: theihs@berlin.vci.de